Assignee
MDXHEALTH RES B V
NL·1 granted patent·5 pending applications·0 citations·filing 2016–2021
Top patents by PatentIndex Score
6 records- 0157US2021246515A1COMBINATION OF mRNA EXPRESSION LEVELS OF DLX1 AND HOXC6 IN URINE AS MOLECULAR MARKERS IN PROSTATE CANCERMDXHEALTH RES B V·Filed 2021·Application pending·0 cites
- 0257US2020165684A1COMBINATION OF mRNA EXPRESSION LEVELS OF DLX1 AND HOXC6 IN URINE AS MOLECULAR MARKERS IN PROSTATE CANCERMDXHEALTH RES B V·Filed 2019·Application pending·0 cites
- 0353US10329625B2Method for detecting DLX1 mRNA, HOXC6 mRNA, and KLK3 mRNA in a urine sample and predicting and treating clinically significant prostate cancerMDXHEALTH RES B V·Filed 2016·Granted Jun 25, 2019·0 cites·8 claims
- 0451US2023151427A1Combinations of molecular markers with improved sensitivity and specificity for predicting and treating prostate cancerMDXHEALTH RES B V·Filed 2021·Application pending·0 cites
- 0545US2016194724A1Combinations of molecular markers with improved sensitivity and specificity for predicting and treating prostate cancerMDXHEALTH RES B V·Filed 2016·Application pending·0 cites
- 0643US2019284641A1Combinations of molecular markers with improved sensitivity and specificity for predicting and treating prostate cancerMDXHEALTH RES B V·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when MDXHEALTH RES B V files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →